IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v8y2017i1d10.1038_ncomms15482.html
   My bibliography  Save this article

Selective BET bromodomain inhibition as an antifungal therapeutic strategy

Author

Listed:
  • Flore Mietton

    (Institut de Biosciences et Biotechnologies de Grenoble, Laboratoire Biologie à Grande Échelle, Université de Grenoble Alpes, CEA, Inserm
    Institut de Biologie Structurale (IBS), Université de Grenoble Alpes, CEA, CNRS)

  • Elena Ferri

    (Dana and David Dornsife College of Letters, Arts and Sciences, University of Southern California, University Park Campus)

  • Morgane Champleboux

    (Institut de Biosciences et Biotechnologies de Grenoble, Laboratoire Biologie à Grande Échelle, Université de Grenoble Alpes, CEA, Inserm)

  • Ninon Zala

    (Institut de Biosciences et Biotechnologies de Grenoble, Laboratoire Biologie à Grande Échelle, Université de Grenoble Alpes, CEA, Inserm)

  • Danièle Maubon

    (Laboratoire de Parasitologie-Mycologie, Institut de Biologie et Pathologie, CHU Grenoble Alpes
    Laboratoire TIMC-IMAG-TheREx, UMR 5525 CNRS, Université Grenoble Alpes)

  • Yingsheng Zhou

    (Dana and David Dornsife College of Letters, Arts and Sciences, University of Southern California, University Park Campus)

  • Mike Harbut

    (California Institute for Biomedical Research)

  • Didier Spittler

    (Institut de Biologie Structurale (IBS), Université de Grenoble Alpes, CEA, CNRS)

  • Cécile Garnaud

    (Laboratoire de Parasitologie-Mycologie, Institut de Biologie et Pathologie, CHU Grenoble Alpes
    Laboratoire TIMC-IMAG-TheREx, UMR 5525 CNRS, Université Grenoble Alpes)

  • Marie Courçon

    (Institut de Biosciences et Biotechnologies de Grenoble, Laboratoire Biologie à Grande Échelle, Université de Grenoble Alpes, CEA, Inserm)

  • Murielle Chauvel

    (Unité Biologie et Pathogénicité Fongiques, Institut Pasteur, INRA)

  • Christophe d’Enfert

    (Unité Biologie et Pathogénicité Fongiques, Institut Pasteur, INRA)

  • Boris A. Kashemirov

    (Dana and David Dornsife College of Letters, Arts and Sciences, University of Southern California, University Park Campus)

  • Mitchell Hull

    (California Institute for Biomedical Research)

  • Muriel Cornet

    (Laboratoire de Parasitologie-Mycologie, Institut de Biologie et Pathologie, CHU Grenoble Alpes
    Laboratoire TIMC-IMAG-TheREx, UMR 5525 CNRS, Université Grenoble Alpes)

  • Charles E. McKenna

    (Dana and David Dornsife College of Letters, Arts and Sciences, University of Southern California, University Park Campus)

  • Jérôme Govin

    (Institut de Biosciences et Biotechnologies de Grenoble, Laboratoire Biologie à Grande Échelle, Université de Grenoble Alpes, CEA, Inserm)

  • Carlo Petosa

    (Institut de Biologie Structurale (IBS), Université de Grenoble Alpes, CEA, CNRS)

Abstract

Invasive fungal infections cause significant morbidity and mortality among immunocompromised individuals, posing an urgent need for new antifungal therapeutic strategies. Here we investigate a chromatin-interacting module, the bromodomain (BD) from the BET family of proteins, as a potential antifungal target in Candida albicans, a major human fungal pathogen. We show that the BET protein Bdf1 is essential in C. albicans and that mutations inactivating its two BDs result in a loss of viability in vitro and decreased virulence in mice. We report small-molecule compounds that inhibit C. albicans Bdf1 with high selectivity over human BDs. Crystal structures of the Bdf1 BDs reveal binding modes for these inhibitors that are sterically incompatible with the human BET-binding pockets. Furthermore, we report a dibenzothiazepinone compound that phenocopies the effects of a Bdf1 BD-inactivating mutation on C. albicans viability. These findings establish BET inhibition as a promising antifungal therapeutic strategy and identify Bdf1 as an antifungal drug target that can be selectively inhibited without antagonizing human BET function.

Suggested Citation

  • Flore Mietton & Elena Ferri & Morgane Champleboux & Ninon Zala & Danièle Maubon & Yingsheng Zhou & Mike Harbut & Didier Spittler & Cécile Garnaud & Marie Courçon & Murielle Chauvel & Christophe d’Enfe, 2017. "Selective BET bromodomain inhibition as an antifungal therapeutic strategy," Nature Communications, Nature, vol. 8(1), pages 1-15, August.
    • Handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15482
    DOI: 10.1038/ncomms15482
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms15482
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/ncomms15482?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15482. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.